Heart cell DNA may unlock genetic clues for rare heart disease
NCT ID NCT03177018
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether DNA can be taken from heart muscle cells to help diagnose arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare heart condition. Researchers collected cells from 34 people during a routine heart procedure. The goal was to see if the DNA from these cells is good enough to find genetic changes linked to the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cardiology-rytmology service
Paris, France
-
University Hospital Toulouse - Cardiology Department
Toulouse, 31000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Global registry aims to unlock clues for heart transplant success in adults born with heart defects
- Heart conditions in kids: study reveals impact on daily life and play
- Gene hunt launched for kids with heart muscle disease
- Heart inflammation clues sought in rare heart disease
- Simple cheek swab could predict sudden cardiac death risk
- Heart disease detective: 1,000-Person study hunts for hidden genetic triggers of sudden cardiac death